<DOC>
	<DOCNO>NCT02452684</DOCNO>
	<brief_summary>To investigate safety efficacy administration eszopiclone 4 week insomnia patient .</brief_summary>
	<brief_title>Investigation Safety Efficacy Eszopiclone Insomnia Patients</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>1 . Insomnia participant take eszopiclone assessment 2 . Participants receive assessment use sleep questionaries</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Insomnia</keyword>
</DOC>